KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169 | -22.1% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $217 | -60.2% | 1 | -66.7% | 0.00% | – |
| Q1 2023 | $545 | -7.6% | 3 | 0.0% | 0.00% | – |
| Q4 2022 | $590 | -41.0% | 3 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 3 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 3 | -50.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 6 | +20.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 5 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 5 | -44.4% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 9 | -40.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 15 | -6.2% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 16 | +14.3% | 0.00% | – |
| Q1 2020 | $1,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |